verapamil has been researched along with Glaucoma in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Excerpt | Relevance | Reference |
---|---|---|
"To study the influence of the calcium channel blocker verapamil on the development of glaucoma in the adrenalin-induced experimental model of glaucoma." | 7.72 | The influence of the calcium channel blocker verapamil on experimental glaucoma. ( Kashintseva, LT; Kopp, OP; Krizhanovsky, GN; Lipovetskaya, EM; Mikheytseva, IN, 2004) |
"We present a case report describing an interaction between topical timolol maleate, verapamil, and flecainide resulting in symptomatic bradycardia." | 7.71 | Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report. ( Herd, A; Minish, T, 2002) |
"To study the influence of the calcium channel blocker verapamil on the development of glaucoma in the adrenalin-induced experimental model of glaucoma." | 3.72 | The influence of the calcium channel blocker verapamil on experimental glaucoma. ( Kashintseva, LT; Kopp, OP; Krizhanovsky, GN; Lipovetskaya, EM; Mikheytseva, IN, 2004) |
"We present a case report describing an interaction between topical timolol maleate, verapamil, and flecainide resulting in symptomatic bradycardia." | 3.71 | Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report. ( Herd, A; Minish, T, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zarbin, MA | 1 |
Irnaten, M | 1 |
Barry, RC | 1 |
Wallace, DM | 1 |
Docherty, NG | 1 |
Quill, B | 1 |
Clark, AF | 1 |
O'Brien, CJ | 1 |
Mikheytseva, IN | 1 |
Kashintseva, LT | 1 |
Krizhanovsky, GN | 1 |
Kopp, OP | 1 |
Lipovetskaya, EM | 1 |
Minish, T | 1 |
Herd, A | 1 |
4 other studies available for verapamil and Glaucoma
Article | Year |
---|---|
Combination therapy to reduce conjunctival scarring after glaucoma surgery.
Topics: Alkylating Agents; Apoptosis; Calcium Channel Blockers; Cicatrix; Conjunctival Diseases; Cyclosporin | 2013 |
Elevated maxi-K(+) ion channel current in glaucomatous lamina cribrosa cells.
Topics: Aged; Aged, 80 and over; Boron Compounds; Calcium; Calcium Channel Blockers; Calcium Channels, L-Typ | 2013 |
The influence of the calcium channel blocker verapamil on experimental glaucoma.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Epinephrine; Glaucoma; Intraocular Pressu | 2004 |
Symptomatic bradycardia secondary to interaction between topical timolol maleate, verapamil, and flecainide: a case report.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agent | 2002 |